HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine

Int J Hematol. 2012 May;95(5):588-91. doi: 10.1007/s12185-012-1050-9. Epub 2012 Mar 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Bendamustine Hydrochloride
  • Female
  • Hepatitis B / diagnosis*
  • Hepatitis B virus / isolation & purification*
  • Humans
  • Lymphoma, Follicular / drug therapy
  • Lymphoma, Follicular / virology
  • Lymphoma, Mantle-Cell / drug therapy
  • Lymphoma, Mantle-Cell / virology
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / virology
  • Middle Aged
  • Nitrogen Mustard Compounds / therapeutic use*
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Nitrogen Mustard Compounds
  • Rituximab
  • Bendamustine Hydrochloride